Generation of a monoclonal antibody recognizing mouse PD-1

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy

Volumn 33, Issue 5, 2014, Pages 361-364

  Qin, Yu E ^a   Wang, Gongze ^a   Yang, Jianlin ^a   Liu, Chao Qi ^a  

^a CHINA THREE GORGES UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; MONOCLONAL ANTIBODY; PROGRAMMED DEATH 1 RECEPTOR; PDCD1 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; ASCITES; CELL FUSION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FLOW CYTOMETRY; HYBRIDOMA; HYBRIDOMA CELL LINE; IMMUNIZATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; GENETICS; IMMUNOLOGY; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; TUMOR CELL LINE;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE; CELL LINE, TUMOR; ESCHERICHIA COLI; HYBRIDOMAS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MICE; MICE, INBRED BALB C; PROGRAMMED CELL DEATH 1 RECEPTOR;

EID: 84912033026     PISSN: None     EISSN: 21679436     Source Type: Journal    
DOI: 10.1089/mab.2014.0024     Document Type: Article

References (9)

1. Gunturi A, and McDermott DF: Potential of new therapies like anti-PD1 in kidney cancer. Curr Treat Opt Oncol 2014; 15(1):137-146.
2. Day CL, Kaufmann DE, Kiepiela P, et al: PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006;443(7109): 350-354.
3. Dong H, Strome SE, Salomao DR, et al: Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 2002;8(8):793-800.
4. Okazaki T, Tanaka Y, Nishio R, et al: Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat Med 2003;9(12): 1477-1483.
5. Qin X, Liu C, Jin Y, et al. Gene expression for murine PD-1 Extracellular domain and preparation of its polyclonal antibody. Chin J Immunol 2010, 10:919-922.
6. Qin X, Liu C, Wang G, et al: Cisplatin induces programmed death-1-ligand 1(PD-L1) over-expression in hepatoma H22 cells via Erk /MAPK signaling pathway. Cell Mol Biol 2010; 56:1366-1372.
7. Zhang P, Su DM, Fu J, et al: Chemopreventive agents induce programmed death-1-ligand 1 (PD-L1) surface expression in breast cancer cells and promote PD-L1-mediated T cell apoptosis. Mol Immunol 2008;45(5):1470-1476.
8. Wei F, Zhong S, Riley JL, et al: Strength of PD-1 signaling differentially affects T-cell effector functions. Proc Natl Acad Sci USA 2013;110(27):E2480-2489.
9. Jurado JO1, Alvarez IB, García VE, et al: Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis. J Immunol 2008;181(1):116-125.